Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe India | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
  • Argentina | es
  • Brazil | pt
  • Canada | fr
  • Canada | en
  • Central America | es
  • Colombia | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh
  • Austria | de
  • Belgium | nl
  • Belgium | fr
  • Bulgaria | bg
  • Czech Republic | en
  • Czech Republic | cs
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | fr
  • Switzerland | de
  • United Kingdom | en
  • Global | en
  • Novartis Foundation | en
  • Sandoz | en
  • Egypt | en
  • Israel | he
  • South Africa | en
  • Turkey | tr

Language & Country Selector for Mobile

language-selector-globe India

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | nl
  • Belgium | fr
  • Brazil | pt
  • Bulgaria | bg
  • Canada | fr
  • Canada | en
  • Central America | es
  • Colombia | es
  • Czech Republic | en
  • Czech Republic | cs
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Israel | he
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Sandoz | en
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | fr
  • Switzerland | de
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About
      • Novartis in India
      • Global Drug Development
      • Strategy
      • Diversity and Inclusion
      • People and Culture
      • Arogya Parivar
      • India Site Locations
      • NIL Board of Directors
        • Mr. Christopher Snook
        • Mr. Sanjay Murdeshwar
        • Mr. Jai Hiremath
        • Ms. Sandra Martyres
        • Ms. Monaz Noble
        • Mr. Sanker Parameswaran
      • Contact
      About
    • Patients and Caregivers
      • Novartis Commitment to Patients and Caregivers
      • Diseases
      • Adverse Event Reporting
      Patients and Caregivers
    • Healthcare Professionals
      • Healthcare professional country resource
      • Novartis Pipeline
      • Adverse Event Reporting
      • Novartis Clinical Trials
      Healthcare Professionals
    • ESG
      • Ethical Behavior
        • Code of Ethics
        • SpeakUp
      • Ethics, Risk and Compliance
      • Access
      • Environmental Sustainability
      • Global Health
      ESG
    • Investors
      • Annual General Meeting
      • Corporate Policies
      • Financial Results
      • Stock Exchange Disclosures
      • Transfer of Shares to IEPF Demat Account
      • Novartis India Investors Contact
      • Novartis India Annual General Meeting
      • Novartis India Board of Directors
      Novartis India Investors
    • News
      • News Archive
      • Contacts
      News
    • Careers
      • Career Search
      • BioCamp
      • Meet the teams
      • Personal Growth
      • Early Talent
      • Well-being
      • Diversity and Inclusion
      • Awards and Recognition
      Careers
    • Coronavirus
      Coronavirus
    Home
  1. Home
  2. Novartis India Investors
  3. Novartis India Annual General Meeting

Novartis India Annual General Meeting

Proceeding of 74th AGM – 29.07.2022

74th AGM – Voting Results and Scrutinizer’s Report

Dividend Tax Communication to Shareholders

Instructions for attending the AGM

Speaker Registration for the AGM

Scrutinizer's Report - Postal Ballot

E-Voting - Postal Ballot

Proceedings of 73rd AGM - 27.08.2021

73rd AGM 2021 - Voting Results and Scrutinizer's Report

Novartis India Limited - 72 Annual General Meeting

Transcript of the 72 Annual General Meeting

E-voting instructions

Intimation for AGM through VC

AGM and E-voting publication

Voting Results

E-voting form 2019

E-voting form(PDF 210 KB)

AGM and E-voting Publication 2017 (PDF 700 KB)

Results of E-voting (PDF 3.56 MB)

E-voting form (PDF 60 KB)

AGM and E-Voting Publication (PDF 818 KB)

Results of E-voting (PDF 11.2 MB)

Results of E-voting (PDF 1.58 MB)

AddToAny buttons

ShareTweetShareWhatsappLinkedinEmail

Printable Links Block (Content)

  • Print
  • PDF

Novartis India

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
  • Contacts
Media Center
  • News Archive
Our Portfolio
  • Novartis Clinical Pipeline
Other Novartis websites
  • Global site
  • Novartis MedHub India
Footer Bottom
© 2022 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Web Accessibility
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for an audience in India